---
title: "SHINEWAY PHARM: Wang Guihua has been appointed as a member of the Nomination Committee"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243813956.md"
description: "According to the Zhitong Finance APP, SHINEWAY PHARM announced that independent non-executive director Wang Guihua has been appointed as a member of the company's nomination committee, effective from June 10, 2025"
datetime: "2025-06-10T04:22:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243813956.md)
  - [en](https://longbridge.com/en/news/243813956.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243813956.md)
---

# SHINEWAY PHARM: Wang Guihua has been appointed as a member of the Nomination Committee

According to the Zhitong Finance APP, SHINEWAY PHARM (02877) announced that independent non-executive director Wang Guihua has been appointed as a member of the company's nomination committee, effective from June 10, 2025

### Related Stocks

- [02877.HK](https://longbridge.com/en/quote/02877.HK.md)

## Related News & Research

- [PegBio appoints Yik Lam Liao as independent director, names her audit chair](https://longbridge.com/en/news/290682093.md)
- [CStone Shareholders Approve All AGM Resolutions, Renew Capital Mandates and CEO Equity Awards](https://longbridge.com/en/news/290618548.md)
- [SoftOx Solutions shareholders approve 2025 annual accounts, report](https://longbridge.com/en/news/290674267.md)
- [Samsung Electronics plans 90 trln won share buyback, Yonhap reports](https://longbridge.com/en/news/290629490.md)
- [Sihuan Pharma enrolls first patient in Phase III trial of anaprazole-based H. pylori eradication therapy](https://longbridge.com/en/news/290382040.md)